LoginRegister
    Eli Lilly new migraine drug Emgality pulls ahead of Amgen in battle for prescriptionsEli Lilly new migraine drug Emgality pulls ahead of Amgen in battle for prescriptions
    Netmeds to add dozen more fulfillment centers in India by 2020Netmeds to add dozen more fulfillment centers in India by 2020
    Fortis tightens financial noose around Singh brothers; likely to move Delhi HCFortis tightens financial noose around Singh brothers; likely to move Delhi HC
    Indoco RemediesIndoco Remedies' new solid dosages facility at Baddi gets UK-MHRA nod
    GSK Consumer Healthcare Q4 profit up 35 percent to Rs 285 croreGSK Consumer Healthcare Q4 profit up 35 percent to Rs 285 crore
    Pfizer gets USFDA approval for Vyndaqel, Vyndamax to treat amyloidosis cardiomyopathyPfizer gets USFDA approval for Vyndaqel, Vyndamax to treat amyloidosis cardiomyopathy
    Indivior signs deal to sell schizophrenia drug Perseris in CanadaIndivior signs deal to sell schizophrenia drug Perseris in Canada
    Following opioid suits, family behind deadly OxyContin squabblesFollowing opioid suits, family behind deadly OxyContin squabbles
    JnJ baby shampoo free from carcinogenic Formaldehyde; says Gujarat FDCAJnJ baby shampoo free from carcinogenic Formaldehyde; says Gujarat FDCA
    Lupin launches generic Clobazam tablets to treat seizuresLupin launches generic Clobazam tablets to treat seizures
    HealthKart raises USD 25 million from Sofina to expand offline networkHealthKart raises USD 25 million from Sofina to expand offline network
    Lupin, Aptissen sign pact to sell Osteoarthritis injection Synolis in CanadaLupin, Aptissen sign pact to sell Osteoarthritis injection Synolis in Canada
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X